$10.450
-0.079 (-0.76%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de CRVS por análisis de gráficos similares
Alphio's CRVS stock price prediction model matches the current Corvus Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $10.27 (-1.69%). The 1-week path is $9.80 (-6.22%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Corvus Pharmaceuticals Inc?
Corvus Pharmaceuticals Inc is a good buy right now due to its current price of $10.53, a year-to-date change of +43.85%, and a recent RSI of 58.681 suggesting bullish momentum. The insider purchase of 21,700 shares by David Scott Moore reflects strong confidence in the company, especially as the stock has surged 217% over the past year. However, the main risk is the negative earnings trend, with a projected EPS of -0.21 for the upcoming earnings report on November 3, 2026.
CRVS cerró en $10.45 el Monday, tras bajar -0.76%
Corvus Pharmaceuticals Inc (CRVS) last closed at $10.4499998, losing -0.76%. These facts feed the 1-day and 1-week CRVS price prediction above.
Consenso de analistas
Corvus Pharmaceuticals Inc (CRVS): 5 comprar, 1 mantener, 0 vender. Perspectiva: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Factores de la previsión
Los factores de la previsión de Corvus Pharmaceuticals Inc (CRVS) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de CRVS, ordenadas por similitud.
Análisis de estacionalidad de CRVS
Historically the probability of a positive October return for CRVS is 100.00%. September offers the highest probability of a positive month at 100.00%, while April is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de CRVS
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Oct 2026 | $3.76 | $4.24 | $5.14 | -59.40% |
| Nov 2026 | $3.46 | $4.05 | $4.05 | -61.26% |
| Dec 2026 | $4.37 | $5.15 | $5.78 | -50.72% |
En 2026, se proyecta que Corvus Pharmaceuticals Inc (CRVS) oscile entre $3.46 y $5.78.
Previsión mensual de Corvus Pharmaceuticals Inc para 2026
En Oct de 2026, se proyecta que Corvus Pharmaceuticals Inc promedie $4.24, con un mínimo de $3.76 y un máximo de $5.14.
En Nov de 2026, se proyecta que Corvus Pharmaceuticals Inc promedie $4.05, con un mínimo de $3.46 y un máximo de $4.05.
En Dec de 2026, se proyecta que Corvus Pharmaceuticals Inc promedie $5.15, con un mínimo de $4.37 y un máximo de $5.78.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.